Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE245223 | GEO | 2023/10/25

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [sgRNA]

Project description:Murine trophoblast organoids contain trophoblast cell types. We used CRISPR SCREENING to analyze the trophoblast organoids derived from TS (mTOs).

2023-10-25 | GSE245217 | GEO

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [scRNA-seq]

Project description:Murine trophoblast organoids contain trophoblast cell types. We used single cell RNA sequencing (scRNA-seq) to analyze the cellular composition of trophoblast organoids derived from placentae (mPOs).

2023-10-25 | GSE225160 | GEO

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening

Project description:Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening

| PRJNA1027430 | ENA

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [sgRNA]

Project description:Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [sgRNA]

| PRJNA1027380 | ENA

Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [scRNA-seq]

Project description:Establishing murine trophoblast organoids as a platform for CRISPR-Cas9 screening [scRNA-seq]

| PRJNA934269 | ENA

Establishing transgenic murine esophageal organoids.

Project description:Organoid systems are commonly used for disease modeling because of their faithful recapitulation of tissue homeostasis, tissue regeneration, and disease processes. However, there is not an optimal approach for the culture of primary mouse esophageal organoids (EOs). Herein, we provide the detailed steps for an efficient and cost-effective protocol for generating and culturing murine EOs. We also describe how to establish transgenic EOs using viral transduction. For complete details on the use and execution of this protocol, please refer to Zheng et al. (2021).

| S-EPMC9048136 | biostudies-literature

Generation of gene-of-interest knockouts in murine organoids using CRISPR-Cas9

Project description:Summary Gene-of-interest knockout organoids present a powerful and versatile research tool to study a gene’s effects on many biological and pathological processes. Here, we present a straightforward and broadly applicable protocol to generate gene knockouts in mouse organoids using CRISPR-Cas9 technology. We describe the processes of transient transfecting organoids with pre-assembled CRISPR-Cas9 ribonucleoprotein complexes, organoid cell sorting, and establishing clonal organoid culture pairs. We then detail how to confirm the knockout via Western blot analysis. Graphical abstract Highlights • Step-by-step protocol to generate clonal gene knockout/parental organoid culture pairs• Gene editing technique designed to minimize genetic and phenotypic off-target effects• Gene knockout organoids are versatile tools for many biological research questions• Broadly accessible protocol due to no prior cloning and reduced equipment requirements Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics. Gene-of-interest knockout organoids present a powerful and versatile research tool to study a gene’s effects on many biological and pathological processes. Here, we present a straightforward and broadly applicable protocol to generate gene knockouts in mouse organoids using CRISPR-Cas9 technology. We describe the processes of transient transfecting organoids with pre-assembled CRISPR-Cas9 ribonucleoprotein complexes, organoid cell sorting, and establishing clonal organoid culture pairs. We then detail how to confirm the knockout via Western blot analysis.

| S-EPMC9918790 | biostudies-literature

Establishing the allosteric mechanism in CRISPR-Cas9.

Project description:Allostery is a fundamental property of proteins, which regulates biochemical information transfer between spatially distant sites. Here, we report on the critical role of molecular dynamics (MD) simulations in discovering the mechanism of allosteric communication within CRISPR-Cas9, a leading genome editing machinery with enormous promises for medicine and biotechnology. MD revealed how allostery intervenes during at least three steps of the CRISPR-Cas9 function: affecting DNA recognition, mediating the cleavage and interfering with the off-target activity. An allosteric communication that activates concerted DNA cleavages was found to led through the L1/L2 loops, which connect the HNH and RuvC catalytic domains. The identification of these "allosteric transducers" inspired the development of novel variants of the Cas9 protein with improved specificity, opening a new avenue for controlling the CRISPR-Cas9 activity. Discussed studies also highlight the critical role of the recognition lobe in the conformational activation of the catalytic HNH domain. Specifically, the REC3 region was found to modulate the dynamics of HNH by sensing the formation of the RNA:DNA hybrid. The role of REC3 was revealed to be particularly relevant in the presence of DNA mismatches. Indeed, interference of REC3 with the RNA:DNA hybrid containing mismatched pairs at specific positions resulted in locking HNH in an inactive "conformational checkpoint" conformation, thereby hampering off-target cleavages. Overall, MD simulations established the fundamental mechanisms underlying the allosterism of CRISPR-Cas9, aiding engineering strategies to develop new CRISPR-Cas9 variants for improved genome editing.

| S-EPMC8315640 | biostudies-literature

A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-07-22 | GSE237974 | GEO

CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease

Project description: Not available

| S-EPMC10432308 | biostudies-literature